J&J homes in on manufacturing restart at Emergent plant behind 15M discarded COVID-19 doses

With production on pause and millions of COVID-19 vaccine doses in limbo, Johnson & Johnson has been hustling to right the ship at CDMO Emergent BioSolutions' troubled Baltimore manufacturing facility. Now, it looks as if relief is in sight.